Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions. Labora
tory Equipment
Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available. Analysis
Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods. Our Library
We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. Aurora Fine Chemicals offers structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production. Our Software
The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics. Our partners and customers
Our customers come from R&D (research and development) labs, the chemical industry, universities and hospitals. Among our customers, there are hundreds of pharmaceutical, chemical and agrochemical companies in the USA, Europe and Japan.
